- Highlights :
- Key Ratio H /
- Income H /
- Balance Sheet H /
- Cash Flow H |
- Details :
- Income D /
- Balance Sheet D /
- Cash Flow D |
NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 2,158 / Fiscal Year End: 2016-12-31 / Stock Type: Mid Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential /

Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
Competitors | AnnualReport
Competitors List | Key Matrix Details
AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | VRTX | INCY | VVUS |Finance Highlights
Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
{##FinanceKeyRatioHighlights}Key Ratio Trend
{##FinanceKeyRatioTrend}Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
ReportDate | PeriodType | Revenue | Cost | InterestEx | Continuous | NetIncome | DilutedSha | ProfitMarg | Continuous | NetMargin |
---|---|---|---|---|---|---|---|---|---|---|
2016-12-25 | Quarter | 300,091k | 64,147k | 8,841k | -78,711k | -78,711k | 172,228,k | 78.60% | -26.20% | -26.20% |
2017-03-25 | Quarter | 303,745k | 50,006k | 9,233k | -16,290k | -16,290k | 172,710,k | 83.50% | -5.40% | -5.40% |
2017-06-25 | Quarter | 317,448k | 56,305k | 9,154k | -36,833k | -36,833k | 174,374,k | 82.30% | -11.60% | -11.60% |
2017-09-25 | Quarter | 334,148k | 59,480k | 9,746k | -12,527k | -12,527k | 175,103,k | 82.20% | -3.70% | -3.70% |
2017-12-25 | Quarter | 358,305k | 75,995k | 10,849k | -51,392k | -51,392k | 175,495,k | 78.80% | -14.30% | -14.30% |
2018-03-25 | Quarter | 373,447k | 82,333k | 10,558k | -44,149k | -44,149k | 176,150,k | 78.00% | -11.80% | -11.80% |
2018-06-25 | Quarter | 372,845k | 79,019k | 11,219k | -16,792k | -16,792k | 176,873,k | 78.80% | -4.50% | -4.50% |
2018-09-25 | Quarter | 391,706k | 78,893k | 11,123k | -12,620k | -12,620k | 177,481,k | 79.90% | -3.20% | -3.20% |
2018-12-25 | Quarter | 353,214k | 75,019k | 7,154k | -3,650k | -3,650k | 178,771,k | 78.80% | -1.00% | -1.00% |
2019-03-25 | Quarter | 400,745k | 89,182k | 6,727k | -56,473k | -56,473k | 178,271,k | 77.70% | -14.10% | -14.10% |
2019-06-25 | Quarter | 387,763k | 77,436k | 6,400k | -37,435k | -37,435k | 179,048,k | 80.00% | -9.70% | -9.70% |
Income Statement Trend
ReportDate | PeriodType | Revenue | Cost | InterestEx | Continuous | NetIncome | DilutedSha | ProfitMarg | Continuous | NetMargin |
---|---|---|---|---|---|---|---|---|---|---|
2017-12-25 | Quarter | 19.40% | 18.47% | 22.71% | -34.71% | -34.71% | 1.90% | 0.25% | -45.42% | -45.42% |
2018-03-25 | Quarter | 22.95% | 64.65% | 14.35% | 171.02% | 171.02% | 1.99% | -6.59% | 118.52% | 118.52% |
2018-06-25 | Quarter | 17.45% | 40.34% | 22.56% | -54.41% | -54.41% | 1.43% | -4.25% | -61.21% | -61.21% |
2018-09-25 | Quarter | 17.23% | 32.64% | 14.13% | 0.74% | 0.74% | 1.36% | -2.80% | -13.51% | -13.51% |
2018-12-25 | Quarter | -1.42% | -1.28% | -34.06% | -92.90% | -92.90% | 1.87% | 0.00% | -93.01% | -93.01% |
2019-03-25 | Quarter | 7.31% | 8.32% | -36.29% | 27.91% | 27.91% | 1.20% | -0.38% | 19.49% | 19.49% |
2019-06-25 | Quarter | 4.00% | -2.00% | -42.95% | 122.93% | 122.93% | 1.23% | 1.52% | 115.56% | 115.56% |
Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
ReportDate | PeriodType | Equity | TotalAsset | TotalLiabi | CurrentAss | CurrentLia | NonCurrent | DebtEquity | CurrentRat |
---|---|---|---|---|---|---|---|---|---|
2016-12-25 | Quarter | 2,766,275k | 4,023,690k | 1,257,415k | 1,421,791k | 439,310k | 818,105k | 2.200 | .309 |
2017-03-25 | Quarter | 2,769,087k | 3,938,607k | 1,169,520k | 1,352,788k | 340,206k | 829,314k | 2.368 | .251 |
2017-06-25 | Quarter | 2,795,579k | 4,019,965k | 1,224,386k | 1,458,820k | 374,303k | 850,083k | 2.283 | .257 |
2017-09-25 | Quarter | 2,813,562k | 4,580,697k | 1,767,135k | 2,050,029k | 417,529k | 1,349,606k | 1.592 | .204 |
2017-12-25 | Quarter | 2,808,663k | 4,633,125k | 1,824,462k | 2,207,144k | 816,518k | 1,007,944k | 1.539 | .370 |
2018-03-25 | Quarter | 2,807,003k | 4,596,717k | 1,789,714k | 2,241,110k | 773,471k | 1,016,243k | 1.568 | .345 |
2018-06-25 | Quarter | 2,885,104k | 4,624,679k | 1,739,575k | 2,280,067k | 804,950k | 934,625k | 1.659 | .353 |
2018-09-25 | Quarter | 2,914,945k | 4,695,254k | 1,780,309k | 2,407,853k | 838,660k | 941,649k | 1.637 | .348 |
2018-12-25 | Quarter | 2,967,940k | 4,427,128k | 1,459,188k | 2,056,215k | 523,241k | 935,947k | 2.034 | .254 |
2019-03-25 | Quarter | 2,936,627k | 4,435,398k | 1,498,771k | 1,916,855k | 500,986k | 997,785k | 1.959 | .261 |
2019-06-25 | Quarter | 9,196k | 0.0 | 0.0 | 1,432,430k | 10,165k | 223,947k | ∞ | .007 |
Balance Sheet Trend
ReportDate | PeriodType | Equity | TotalAsset | TotalLiabi | CurrentAss | CurrentLia | NonCurrent | DebtEquity | CurrentRat |
---|---|---|---|---|---|---|---|---|---|
2017-12-25 | Quarter | 1.53% | 15.15% | 45.10% | 55.24% | 85.86% | 23.20% | -30.05% | 19.74% |
2018-03-25 | Quarter | 1.37% | 16.71% | 53.03% | 65.67% | 127.35% | 22.54% | -33.78% | 37.45% |
2018-06-25 | Quarter | 3.20% | 15.04% | 42.08% | 56.30% | 115.05% | 9.95% | -27.33% | 37.35% |
2018-09-25 | Quarter | 3.60% | 2.50% | 0.75% | 17.45% | 100.86% | -30.23% | 2.83% | 70.59% |
2018-12-25 | Quarter | 5.67% | -4.45% | -20.02% | -6.84% | -35.92% | -7.14% | 32.16% | -31.35% |
2019-03-25 | Quarter | 4.62% | -3.51% | -16.26% | -14.47% | -35.23% | -1.82% | 24.94% | -24.35% |
2019-06-25 | Quarter | -99.68% | -100.00% | -100.00% | -37.18% | -98.74% | -76.04% | -100.00% | -98.02% |